Quarterly report pursuant to Section 13 or 15(d)

Acquisition - Summary of Fair Value of Consideration (Detail)

v3.19.2
Acquisition - Summary of Fair Value of Consideration (Detail) - USD ($)
Jun. 11, 2018
May 31, 2019
Nov. 30, 2018
Consideration      
Cord blood inventory earnout   $ 3,612,048 $ 4,282,975
Blood Bank Inc and Tianhe Stem Cell Biotechnologies Inc [Member]      
Consideration      
Cash $ 10,500,000    
Cryo-Cell common stock 3,500,000    
Cord blood inventory earnout 4,698,255    
Consideration $ 18,698,255